Physician profile
Morgan Eldridge
NPI 1639660087
$15,078.14
in general payments reported to CMS, 2019-2025
18 companies · $2,211 in 2025
The $2,211 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,925 · 2022: $4,495 · 2023: $1,954 · 2024: $4,494 · 2025: $2,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,489 · Travel and Lodging: $1,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,489.05 |
| Travel and Lodging | $1,169.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13,021.19 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Vertos Medical, INC. | $873.92 | 2022-2024 | Mild Device Kit |
| Curonix LLC | $214.51 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Si-Bone, INC. | $196.49 | 2023-2024 | |
| Painteq LLC | $142.22 | 2024 | Painteq |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2025 | |
| Novo Nordisk INC | $120.73 | 2022-2023 | Wegovy |
| Alkermes, INC. | $100.00 | 2022 | |
| Amgen INC. | $85.71 | 2023-2024 | Evenity, Prolia |
| Medtronic, INC. | $31.35 | 2024 | Synchromedii |
| Spr Therapeutics, INC | $25.85 | 2024 | Sprint Pns System |
| Corcept Therapeutics | $24.00 | 2023 | Korlym |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.13 | 2022 | |
| Protega Pharmaceutials INC | $20.93 | 2022 | |
| Grt US Holding, INC. | $19.88 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $19.19 | 2021 | |
| Hikma Pharmaceuticals USA | $18.24 | 2022 | |
| Glaxosmithkline, LLC. | $17.80 | 2025 | Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Eldridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.